Visine L.R. Long Lasting Redness Relief Interactions
There are 49 drugs known to interact with Visine L.R. Long Lasting Redness Relief (oxymetazoline ophthalmic), along with 4 disease interactions. Of the total drug interactions, 6 are major, and 43 are moderate.
- View all 49 medications that may interact with Visine L.R. Long Lasting Redness Relief
- View Visine L.R. Long Lasting Redness Relief disease interactions (4)
Most frequently checked interactions
View interaction reports for Visine L.R. Long Lasting Redness Relief (oxymetazoline ophthalmic) and the medicines listed below.
- amantadine
- amlodipine
- Aspirin Low Strength (aspirin)
- atenolol
- Azilect (rasagiline)
- Bactrim (sulfamethoxazole / trimethoprim)
- bisacodyl
- bismuth subsalicylate
- Calcium, Magnesium and Zinc (multivitamin with minerals)
- carbidopa / levodopa
- carvedilol
- Centrum Silver (multivitamin with minerals)
- Cervidil (dinoprostone topical)
- cetirizine
- cinnamon
- clomiphene
- clotrimazole
- Depo Provera (medroxyprogesterone)
- diazepam
- etomidate
- Exparel (bupivacaine liposome)
- High Potency B Complex with B12 and C (multivitamin)
- hydrochlorothiazide
- Imodium (loperamide)
- interferon alfa-2b
- ketamine
- lisinopril
- losartan
- Methergine (methylergonovine)
- methohexital
Visine L.R. Long Lasting Redness Relief disease interactions
There are 4 disease interactions with Visine L.R. Long Lasting Redness Relief (oxymetazoline ophthalmic) which include:
Report options
QR code containing a link to this page
More about Visine L.R. Long Lasting Redness Relief (oxymetazoline ophthalmic)
- Visine L.R. Long Lasting Redness Relief consumer information
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- Drug class: ophthalmic antihistamines and decongestants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
